These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 5076088)

  • 1. Delta-aminolaevulinic acid in acute porphyria.
    Shanley BC; Taljaard JJ; Deppe WM; Joubert SM
    S Afr Med J; 1972 Jun; 46(25):864. PubMed ID: 5076088
    [No Abstract]   [Full Text] [Related]  

  • 2. Delta-aminolaevulinic acid in acute porphyria.
    Eales L
    S Afr Med J; 1972 May; 46(19):595. PubMed ID: 5076897
    [No Abstract]   [Full Text] [Related]  

  • 3. Delta-aminolaevulinic acid in acute porphyria.
    Shanley BC; Taljaard JJ; Deppe WM; Joubert SM
    S Afr Med J; 1972 Jan; 46(4):84. PubMed ID: 5058669
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of the porphyrin precursors delta-aminolaevulinic acid (ALA) and porphobilinogen (PBG) in the acute attack of porphyria.
    Kramer S; Becker D; Viljoen D
    S Afr Med J; 1973 Sep; 47(38):1735-8. PubMed ID: 4270402
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute intermittent porphyria. A clinical, biochemical and family study.
    Kreimer-Birnbaum M; Mosovich LL; Bannerman RM
    J Med; 1971; 2(3):149-66. PubMed ID: 5289639
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute intermittent porphyria with seizures. Anticonvulsant medication-induced metabolic changes.
    Birchfield RI; Cowger ML
    Am J Dis Child; 1966 Dec; 112(6):561-5. PubMed ID: 5928821
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropharmacology of delta-aminolaevulinic acid. II. Effect of chronic administration in mice.
    Edwards S; Jackson D; Reynoldson J; Shanley B
    Neurosci Lett; 1984 Sep; 50(1-3):169-73. PubMed ID: 6493622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute intermittent porphyria in Poland.
    Darocha T; Gregor A
    S Afr Med J; 1971 Sep; ():204-17. PubMed ID: 5150281
    [No Abstract]   [Full Text] [Related]  

  • 9. Deferoxamine in the treatment of porphyria.
    Taxay EP
    South Med J; 1972 Oct; 65(10):1186-212. PubMed ID: 5074089
    [No Abstract]   [Full Text] [Related]  

  • 10. Delta-aminolaevulinic acid synthetase activity in normal and porphyric human livers.
    Dowdle EB; Mustard P; Eales L
    S Afr Med J; 1967 Nov; 41(42):1093-6. PubMed ID: 6061512
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyridoxal phosphate in acute intermittent porphyria.
    Hamfelt A; Wetterberg L
    Ann N Y Acad Sci; 1969 Sep; 166(1):361-4. PubMed ID: 5262030
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modifications of rhythm of urinary excretion of delta-aminolevulic acid and of porphobilinogen induced by glycine load in relatives of patients with acute porphyria].
    Prato V; Massaro AL; Mazza U; Fiorina L
    Minerva Med; 1965 Oct; 56(86):3652-7. PubMed ID: 5841672
    [No Abstract]   [Full Text] [Related]  

  • 13. Delta-aminolevulinic acid in plasma by free amino acid analysis.
    Hannan CJ; Kettler T; Dabe I; Clark T
    Clin Chem; 1989 Sep; 35(9):1998. PubMed ID: 2776336
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute intermittent porphyria.
    Day RS; Eales L
    S Afr Med J; 1982 Feb; 61(8):260-1. PubMed ID: 7058452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of acute porphyrias. The importance of follow-up of patients and carriers].
    Tasnádi G; Bor M; Pusztai A
    Orv Hetil; 2003 May; 144(19):933-8. PubMed ID: 12809070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anticonvulsant drugs on serum delta-aminolaevulinic acid levels in non-porphyric subjects.
    Gorchein A; Webber R; Burnett D; Goudie JH
    Br J Clin Pharmacol; 1987 Dec; 24(6):847-8. PubMed ID: 3440108
    [No Abstract]   [Full Text] [Related]  

  • 17. Porphyrin precursors in acute porphyria.
    Eales L
    S Afr Med J; 1978 Jan; 53(3):79-80. PubMed ID: 653477
    [No Abstract]   [Full Text] [Related]  

  • 18. The porphyrias.
    Moore MR; McColl KE; Goldberg A
    Diabete Metab; 1979 Dec; 5(4):323-36. PubMed ID: 398301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute intermittent porphyria].
    Wetterberg L
    Lakartidningen; 1974 Jun; 71(24):2461-5. PubMed ID: 4599136
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurochemical aspects of porphyria. Studies on the possible neurotoxicity of delta-aminolaevulinic acid.
    Shanley BC; Neethling AC; Percy VA; Carstens M
    S Afr Med J; 1975 Mar; 49(14):576-80. PubMed ID: 1145380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.